LongevityFrontier ResearchLimited availability

Senolytic Therapy

Pharmaceutical clearing of senescent 'zombie' cells that drive aging and chronic disease

4.3280 verified reviews
2-3 days/month$200 - $800/cycle

Availability varies by city. Gabriel can help find a practitioner or adjacent option.

Senolytic Therapy
Visit PreviewLongevity

During the visit

Baseline testing: p16INK4a levels, inflammatory markers (IL-6, TNF-alpha, CRP), metabolic panel

Protocol typically involves dasatinib + quercetin taken for 2-3 consecutive days

Repeated monthly or quarterly depending on senescence burden

Fisetin protocols: higher doses (1-2g) taken for 2 consecutive days monthly

Duration

2-3 days/month

Starting at

$200

Practitioner access

Ask Gabriel

Category

Longevity

About this treatment

What this treatment is designed to do

Senolytic therapy uses targeted pharmaceutical compounds to selectively destroy senescent cells — damaged cells that refuse to die and instead accumulate with age, secreting inflammatory signals (the SASP — senescence-associated secretory phenotype) that accelerate aging in surrounding healthy tissue. These 'zombie cells' are now recognized as a primary driver of aging and age-related diseases.

The most studied senolytic protocols combine dasatinib (a cancer drug that targets senescent cell survival pathways) with quercetin (a plant flavonoid that enhances the effect). Other emerging senolytics include fisetin (a strawberry-derived flavonoid showing remarkable results in animal studies) and navitoclax (BCL-2 inhibitor). These compounds are taken in periodic 'hit and run' doses — typically 2-3 days per month — rather than continuously.

Mayo Clinic research has demonstrated that clearing just 30% of senescent cells in mice extends healthspan by 36% and reverses multiple age-related conditions. Human trials at Mayo and other institutions are showing promising early results in idiopathic pulmonary fibrosis, diabetic kidney disease, and frailty. Longevity physicians are now prescribing senolytic protocols off-label for patients with elevated markers of cellular senescence.

Visit flow

What happens during the session

1

Baseline testing: p16INK4a levels, inflammatory markers (IL-6, TNF-alpha, CRP), metabolic panel

2

Protocol typically involves dasatinib + quercetin taken for 2-3 consecutive days

3

Repeated monthly or quarterly depending on senescence burden

4

Fisetin protocols: higher doses (1-2g) taken for 2 consecutive days monthly

5

Some patients report a 'clearing reaction' with mild fatigue for 24-48 hours post-dose

6

Follow-up labs at 3-6 months to measure reduction in inflammatory and senescence markers

Best for

Why people usually choose this

Adults 40+ interested in proactive longevity medicine

Anyone with elevated inflammatory markers and accelerated biological age

Patients with idiopathic pulmonary fibrosis (clinical trial indication)

Chronic disease patients with high senescent cell burden

Key outcomes

What people hope to improve

Targets a root cause of aging — senescent cell accumulation

Mayo Clinic research: 36% healthspan extension in animal models

Reduces chronic inflammation driven by SASP

Improves physical function and reduces frailty markers

Gabriel intelligence

How Gabriel makes this treatment more actionable

Treatment fit

Root-cause context before you book

Gabriel can help decide whether senolytic therapy fits your symptoms, labs, and recovery goals before you spend money on a session.

Protocol pairing

Connect sessions to a real plan

Gabriel can pair this with diagnostics, supplements, peptides, and follow-up cadence so it fits into a real protocol instead of sitting in isolation.

Practitioner match

Find the right clinic, not just the nearest one

Gabriel uses trust, treatment fit, and modality overlap to surface practitioners who are more likely to be a strong match for this exact treatment path.

Evidence & safety

What to know before committing

Strong preclinical evidence. Human clinical trials ongoing at Mayo Clinic and other institutions. Dasatinib has known side effects (it's a cancer drug) — requires physician oversight. Quercetin and fisetin have excellent safety profiles. This is NOT a DIY protocol — medical supervision essential for dasatinib-containing regimens.

Not sure if this treatment is the right next move?

Tell Gabriel what you are dealing with and what you have already tried. You will get a more useful answer than a generic treatment directory can give.